FLSC 10-Q: SEC filing

Frazier Life Sciences Acquisition Corp. II

Filed with the SEC on · accession 0001193125-26-465479

FLSC filed a 10-Q (quarterly report) with the SEC on Nov 17, 2026. The quarterly report: unaudited results for the quarter plus management’s comments.

Summary of the filing

Frazier Life Sciences Acquisition Corp. II filed its Q3 2026 Form 10-Q, reporting financial results for the quarter ended September 30, 2026, and disclosing subsequent events including its October 15, 2026 IPO closing.

Key details

RegistrantFrazier Life Sciences Acquisition Corp. II

✦ Ask GOAX AI about this filing — what it means for FLSC, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for FLSC?

Click here

Frequently asked questions

What did FLSC file with the SEC on Nov 17, 2026?

FLSC filed a 10-Q (SEC filing). Frazier Life Sciences Acquisition Corp. II filed its Q3 2026 Form 10-Q, reporting financial results for the quarter ended September 30, 2026, and disclosing subsequent events including its October 15, 2026 IPO closing.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

Other FLSC SEC filings

Get alerts when FLSC files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days